Excerpt from their article:
Nova and his team at San Diego-based Pathway Genomics believe the CannabisDNA test – costing you $129 — can provide the data needed to take the guesswork out of the emerging therapies.
“It’s a great tool for physicians who prescribe the products, and dispensaries are really hot for it because it can help their customers decide what’s best for them to buy,” Nova tells Newsmax. “In effect, we’re personalizing the therapeutic cannabis experience.”
Read the full article here: https://www.newsmax.com/newsfront/cannabis-genetics-pathway-ome-cannabis-dna-insight/2019/03/13/id/906789/